Pi-Sunyer X, Astrup A, Fujioka K, et al
For example, if you have 2.5mg/mL concentration and want a 0.5mg dose: (0.5 2.5) 100 = 20 IU
Pharmaceuticals (Basel) 2023
Certain patient populations warrant thorough discussion of liver-related considerations before initiating GLP-1 receptor agonist therapy
To qualify for Wegovy, youll typically need one of the following: A BMI of 30 or higher (classified as obesity ), or A BMI of 27 or higher with at least one weight-related health condition Weight-related conditions may include: High blood pressure (hypertension) High cholesterol (dyslipidemia) Type 2 diabetes Heart disease Obstructive sleep apnea Polycystic ovary syndrome ( PCOS ) In addition, in March 2024 the FDA expanded Wegovys approval to include reducing the risk of major cardiovascular events like heart attac k, stroke, and cardiovascular death in adults with cardiovascular disease plus overweight or obesity
Let the vial sit 15 to 30 minutes without shaking, swirl gently, and check the certificate of analysis for the correct solvent
